Identification of a promiscuous T-cell epitope encoded by multiple members of the mage family

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2668-2674

  Tanzarella, Silvia ^a   Russo, Vincenzo ^a   Lionello, Ilaria ^a   Dalerba, Piero ^a   Rigatti, Donata ^a   Bordignon, Claudio ^a   Traversari, Catia ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL STRAIN COS1; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; BASE SEQUENCE; EPITOPES; HLA-B ANTIGENS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033151628     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Boon, T., Coulie, P. G., and Van den Eynde, B. Tumor antigens recognized by T cells. Immunol. Today, 18: 267-268, 1997.
2. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J. L., Laurent, C., Naeyaert, J. M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
3. Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dréno, B., Tessier, M-H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck, R., Liénard, D., Beauduin, M., Dietrich, P-H., Traversari, C., Kerger, J., Masucci, G., Jäger, E., De Greve, J., Atzpodien, J., Brasseur, F., Coulie, P. G., van der Bruggen, P., and Boon, T. Regressions observed in metastatic melanoma of patients treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer, 80: 219-230, 1999.
4. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide-or tumor lysatepulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
5. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., Wunderlich, J. R., Parkhurst, M. R., Kawakami, Y., Seipp, C. A., Einhorn, J. H., and White, D. E. Immunological and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med., 4: 321-327, 1998.
6. Van den Eynde, B. J., and van der Bruggen, P. T cell defined tumor antigens. Curr. Opin. Immunol., 9: 684-693, 1997.
7. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
8. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
9. Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2: 167-175, 1995.
10. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
11. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. Cloning of the gene coding for a shared human melanoma antigen recognized by aulologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
12. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
13. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91: 6458-6463, 1994.
14. Wang, R., Robbins, P. F., Kawakami, Y., Kang, X., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognised by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799-804, 1995.
15. Wang, R-F., Parkhurst, M., Kawakami, Y., Robbins, P. F., and Rosenberg, S. A. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med., 183: 1131-1140, 1996.
16. Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer Zum Buschenfelde, K-H., and Beach, D. A. p16INK4a-insensitive CDK4 mutant targeted by cylolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
17. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA, 92: 7976-7980, 1995.
18. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated B-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
19. Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., and Traversari, C. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J. Exp. Med., 188: 1005-1016, 1998.
20. Weynants, P., Lethé, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer, 56: 826-829, 1994.
21. Patard, J. J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., François, P., Abi-Aad, A., Van Cangh, P., Abbou, C. C., Chopin, D., and Boon, T. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64: 60-64, 1995.
22. Russo, V., Traversari, C., Verrecchia, A., Mottolese, M., Natali, P. G., and Bordignon, C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int. J. Cancer, 64: 1-6, 1995.
23. Russo, V., Dalerba, P., Ricci, A., Bonazzi, C., Leone, B. E., Mangioni, C., Allavena, P., Bordignon, C., and Traversari, C. MAGE, BAGE, and GAGE genes expression in fresh epithelial ovarian carcinomas. Int. J. Cancer, 67: 457-461, 1996.
24. Restifo, N. P., Marincola, M. F., Kawakami, Y., Taubenberger, J., Yannelli, J. R., and Rosenberg, S. A. Loss of functional β2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst. (Bethesda), 88: 100-108, 1996.
25. Van den Eynde, B., Hainaut, P., Herin, M., and Knuth, A. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer, 44: 634-640, 1989.
26. Fleischhauer, K., Gattinoni, L., Dalerba, P., Lauvau, G., Zanaria, E., Dabovic, B., van Endert, P. M., Bordignon, C., and Traversari, C. The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes. Cancer Res., 58: 2969-2972, 1998.
27. Herman, J., van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T., and Coulie, P. G. A peptide encoded by human gene Mage-3 induces cytolytic T lymphocytes that recognizes tumor cells expressing Mage-3. Immunogenetics, 43: 377-384, 1996.
28. Fleischhauer, K., Tanzarella, S., Russo, V., Sensi, M. L., van der Bruggen, P., Bordignon, C., and Traversari, C. Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones. J. Immunol., 159: 2513-2521, 1997.
29. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
30. De Smet, C., Lurquin, C., van der Bruggen, P., De Plaen, E., Brasseur, F., and Boon, T. Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics, 39: 121-129, 1994.
31. Rammensee, H. G., Friede, T., and Stefanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
32. Dalerba, P., Ricci, A., Russo, V., Rigatti, D., Nicotra, M. R., Mottolese, M., Bordignon, C., Natali, P. G., and Traversari, C. High homogeneity of Mage, Bage, Gage, Tyrosinase and Melan-A/MART-I gene expression in clusters of multiple simultaneous metastases of human melanoma: implication for protocol design of therapeutic antigen-specific vaccination strategies. Int. J. Cancer, 77: 200-204, 1998.
33. Jäger, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F., and Knuth, A. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71: 142-147, 1997.
34. Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Parmiani, G., Storkus, W. J., and Lotze, M. T. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with down-regulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Invest., 98; 1633-1641, 1996.
35. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., and Coulie, P. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol., 25: 340-347, 1995.
36. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. Natural history of HLA expression during tumor development. Immunol. Today, 14: 491-499, 1993.
37. Ferrone, S., and Marincola, F. M. Loss of HLA class 1 antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16: 487-494, 1995.
38. de Vries, T. J., Fourkour, A., Wobbes, T., Verkroost, G., Ruiter, D. J., and van Muijen, G. N. P. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res., 57: 3223-3229, 1997.
39. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J. F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., and Coulie, P. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6: 199-208, 1997.
40. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
41. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
42. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
43. Wölfel, T., Hauer, M., Klehmann, E., Brichard, V., Ackermann, B., Knuth, A., Boon, T., and Meyer Zum Uschenfelde, K. H. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolylic lymphocytes (CTL). Int. J. Cancer, 55: 237-244, 1993.
44. Crowley, N. J., Darrow, T. L., Quinn-Allen, M. A., and Seigler, H. F. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J. Immunol., 146: 1692-1699, 1991.
45. Visseren, M. J. W., van der Burg, S. H., van der Voort, E. I. H., Brandt, R. M. P., Schrier, P. I., van der Bruggen, P., Boon, T., Melief, C. J. M., and Kast, W. M. Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product. Int. J. Cancer, 73: 125-130, 1997.
46. Groettrup, M., Soza, A., Kuckelkorn, U., and Kloetzel, P. M. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today, 17: 429-435, 1996.
47. Coux, O., Tanaka, K., and Goldberg, A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem., 65: 801-847, 1996.